Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95


Enhancement of identifying cancer specialists through the linkage of Medicare claims to additional sources of physician specialty.

Pollack LA, Adamache W, Eheman CR, Ryerson AB, Richardson LC.

Health Serv Res. 2009 Apr;44(2 Pt 1):562-76. doi: 10.1111/j.1475-6773.2008.00935.x. Epub 2008 Dec 15.


Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement.

Baldwin LM, Adamache W, Klabunde CN, Kenward K, Dahlman C, L Warren J.

Med Care. 2002 Aug;40(8 Suppl):IV-82-95.


Creating a National Provider Identifier (NPI) to Unique Physician Identification Number (UPIN) Crosswalk for Medicare Data.

Parsons HM, Enewold LR, Banks R, Barrett MJ, Warren JL.

Med Care. 2015 Dec 17. [Epub ahead of print]


Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years.

Pollack LA, Adamache W, Ryerson AB, Eheman CR, Richardson LC.

Cancer. 2009 Nov 15;115(22):5284-95. doi: 10.1002/cncr.24624.


Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States.

Austin S, Martin MY, Kim Y, Funkhouser EM, Partridge EE, Pisu M.

Health Serv Res. 2013 Jun;48(3):1135-53. doi: 10.1111/1475-6773.12012. Epub 2012 Dec 3.


Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.

Goulart BH, Reyes CM, Fedorenko CR, Mummy DG, Satram-Hoang S, Koepl LM, Blough DK, Ramsey SD.

J Oncol Pract. 2013 Jan;9(1):42-50. doi: 10.1200/JOP.2012.000640.


Medicare physician referral patterns.

Shea D, Stuart B, Vasey J, Nag S.

Health Serv Res. 1999 Apr;34(1 Pt 2):331-48.


Physician visits prior to treatment for clinically localized prostate cancer.

Jang TL, Bekelman JE, Liu Y, Bach PB, Basch EM, Elkin EB, Zelefsky MJ, Scardino PT, Begg CB, Schrag D.

Arch Intern Med. 2010 Mar 8;170(5):440-50. doi: 10.1001/archinternmed.2010.1.


Analysis of services received under Medicare by specialty of physician.

Pine PL, Gornick M, Lubitz J, Newton M.

Health Care Financ Rev. 1981 Sep;3(1):89-116.


An algorithm for the use of Medicare claims data to identify women with incident breast cancer.

Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL.

Health Serv Res. 2004 Dec;39(6 Pt 1):1733-49.


Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.

Ramsey SD, Scoggins JF, Blough DK, McDermott CL, Reyes CM.

J Manag Care Pharm. 2009 Oct;15(8):659-68.


Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.

Du X, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS.

Med Care. 2000 Jul;38(7):719-27.


Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL.

Am J Epidemiol. 2011 Oct 1;174(7):860-70. doi: 10.1093/aje/kwr146. Epub 2011 Aug 4.


Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.

Yang W, Williams JH, Hogan PF, Bruinooge SS, Rodriguez GI, Kosty MP, Bajorin DF, Hanley A, Muchow A, McMillan N, Goldstein M.

J Oncol Pract. 2014 Jan;10(1):39-45. doi: 10.1200/JOP.2013.001319.


The generalist role of specialty physicians: is there a hidden system of primary care?

Rosenblatt RA, Hart LG, Baldwin LM, Chan L, Schneeweiss R.

JAMA. 1998 May 6;279(17):1364-70.


Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.

Kent EE, Malinoff R, Rozjabek HM, Ambs A, Clauser SB, Topor MA, Yuan G, Burroughs J, Rodgers AB, DeMichele K.

J Am Geriatr Soc. 2016 Jan;64(1):186-92. doi: 10.1111/jgs.13888.


Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.

Onukwugha E, Yong C, Hussain A, Seal B, Mullins CD.

BMC Med Res Methodol. 2014 Jan 2;14:1. doi: 10.1186/1471-2288-14-1.


Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.

Sanoff HK, Carpenter WR, Martin CF, Sargent DJ, Meyerhardt JA, Stürmer T, Fine JP, Weeks J, Niland J, Kahn KL, Schymura MJ, Schrag D.

J Natl Cancer Inst. 2012 Feb 8;104(3):211-27. doi: 10.1093/jnci/djr524. Epub 2012 Jan 20.

Supplemental Content

Support Center